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NDST1Impaired heparan sulfate (HS) synthesis in vertebrate development causes complex malformations due to the
functional disruption of multiple HS-binding growth factors and morphogens. Here, we report developmental
heart defects in mice bearing a targeted disruption of the HS-generating enzyme GlcNAc N-deacetylase/GlcN
N-sulfotransferase 1 (NDST1), including ventricular septal defects (VSD), persistent truncus arteriosus (PTA),
double outlet right ventricle (DORV), and retroesophageal right subclavian artery (RERSC). These defects closely
resemble cardiac anomalies observed inmicemade deﬁcient in the cardiogenic regulatorﬁbroblast growth factor
8 (FGF8). Consistentwith this,we show thatHS-dependent FGF8/FGF-receptor2C assembly and FGF8-dependent
ERK-phosphorylation are strongly reduced in NDST1−/− embryonic cells and tissues. Moreover, WNT1-Cre/
LoxP-mediated conditional targeting of NDST function in neural crest cells (NCCs) revealed that their impaired
HS-dependent development contributes strongly to the observed cardiac defects. These ﬁndings raise the possi-
bility that defects in HS biosynthesis may contribute to congenital heart defects in humans that represent the
most common type of birth defect.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Neural crest cells (NCCs) are ecto-mesenchymal cells that migrate
from the dorsal surface of the embryo to populate numerous structures
along the dorsoventral axis. Cranial NCCs arise from the forebrain and
hindbrain region to populate craniofacial structures as well as pharyn-
geal arches (PA) 1–3, giving rise to the maxilla, mandible and other
structures of theneck and face. The cardiac neural crest (CNC) originates
between the otic placode and the 3rd somite in the chick (Kuratani and, Double outlet right ventricle;
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ights reserved.Kirby, 1992) and populates the third, fourth, and sixth PA as well as the
outﬂow tract (OFT) of the heart. Experimental models that ablate CNCs
result in characteristic cardiovascular abnormalities such as failure of
OFT septation and aortic arch artery defects (reviewed by (Kirby and
Waldo, 1995)). Mouse models with abnormal NCC development also
show these characteristic abnormalities (reviewed by Maschhoff and
Baldwin, 2000), and several human birth defect syndromes, called
22q11 deletion syndromes, are thought to result fromdefective NCC de-
velopment. 22q11 deletion syndromes result in failure of OFT septation
(persistent truncus arteriosus (PTA), ventricular septal defects (VSDs),
abnormal rotation and alignment of the OFT with the ventricles, double
outlet right ventricle (DORV) and tetralogy of Fallot) or abnormal pat-
terning of the aortic arch arteries. Craniofacial ﬁndings in these syn-
dromes include cleft palate, abnormal facial features and external ear
defects. An important family of factors involved in the formation of
these syndromes and required for the survival, migration, proliferation
and differentiation of NCCs are the ﬁbroblast growth factors (FGFs)
and their receptors (FGFRs). FGF1, FGF2, FGF9, FGF16, FGF20, FGFR1
and FGFR2 are expressed in mouse and chick ventricles during cardiac
development (Colvin et al., 1999; Dell'Era et al., 2003; Pennisi et al.,
2003; Lavine et al., 2005; Hotta et al., 2008) and activate cardiomyoblast
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FGF2 function, however, develop normally and have normal cardiac
structure and mass (Zhou et al., 1998; Schultz et al., 1999; Miller et al.,
2000). This indicates compensatory activities among FGF family
members. FGF8, however, encodes a crucial member of the FGF family,
providing survival, mitogenic, anti/-pro differentiation and patterning
signals to adjacent tissues as well as autocrine activity (Park et al.,
2008). Complete loss of FGF8 function in mice leads to early embryonic
lethality (Meyers et al., 1998; Sun et al., 1999; Moon and Capecchi,
2000), and murine FGF8 hypomorphic mutants have a constellation of
heart, OFT, great vessel and pharyngeal defects (Abu-Issa et al., 2002;
Frank et al., 2002). Mesodermal FGF8 and FGF10 have overlapping
roles in heart development (Watanabe et al., 2010). FGF9 is expressed
in themidgestationmouse heart and regulatesmyocardial proliferation
and differentiation in vivo (Lavine et al., 2005). FGF9 deﬁcient mice die
at birth with an enlarged dilated heart (Colvin et al., 1999).
FGF family members and their receptors require heparan sulfate
(HS) for the formation of high afﬁnity FGF- and FGFR-complexes and
subsequent signaling (Rapraeger et al., 1991; Yayon et al., 1991). HS is
produced by most mammalian cells as part of membrane and extra-
cellular matrix proteoglycans (the HSPGs) (Esko and Lindahl, 2001).
The polysaccharide chain grows by exostosin (Ext) copolymerization
of GlcAβ1,4 and GlcNAcα1,4 and is modiﬁed by one or more of the
four NDST isozymes; the N-deacetylase activity of NDSTs removes ace-
tyl groups from GlcNAc residues, which are then converted to GlcNS
through the N-sulfotransferase activity. Subsequent modiﬁcations of
the HS chain by most O-sulfotransferases and a GlcA C5-epimerase de-
pend on the presence of GlcNS residues, making the NDSTs responsible
for the generation of sulfated HS ligand binding sites (Lindahl et al.,
1998). Mice deﬁcient in EXT1, NDST1, 2-O-sulfotransferase and GlcA
C5-epimerase show defective brain morphogenesis, axon guidance
defects, craniofacial defects, defective formation of the lacrimal glands,
skeletal defects, renal agenesis and eye defects due to simultaneous
inhibition of multiple HS-binding factors (Bullock et al., 1998; Inatani
et al., 2003; Li et al., 2003; McLaughlin et al., 2003; Grobe et al., 2005;
Pan et al., 2006; Pallerla et al., 2007; Pan et al., 2008; Iwao et al.,
2009). Mice deﬁcient for the HSPG Glypican3 (GLP3) show defective
heart development, as do mice lacking the HSPG Perlecan (Cano-Gauci
et al., 1999; Costell et al., 2002; Ng et al., 2009). In humans, mutations
in B3GAT3, the gene coding for glucuronosyltransferase-I (GlcAT-I), re-
sult in variable combinations of heart malformations, including mitral
valve prolapse, VSD, and bicuspid aortic valve (Baasanjav et al., 2011).
Importantly, craniofacial defects in NDST1-deﬁcient mouse embryos
are consistent with NCC deﬁciencies and resemble mutants deﬁcient
in Sonic hedgehog (SHH) and FGF8 function (Grobe et al., 2005). There-
fore, we analyzed these mice for SHH/FGF- and NCC-related cardiac
developmental defects, and found that NDST1 null mice indeed show
multiple cardiovascular malformations, in large part due to impaired
NCC function.
2. Results
2.1. Heart defects in NDST1 deﬁcient embryos
FGF2 signaling and thedevelopment of NCC-derived facial and crani-
al structures are impaired in NDST1 null embryos (Grobe et al., 2005;
Pallerla et al., 2007). Therefore, we analyzed E14.5 (n = 4) and E18.5
(n = 7) NDST1−/− embryos for potential FGF- and NCC-dependent
developmental defects of the cardiovascular system. We detected
membranous VSD in all E18.5 NDST1−/− mutants (Fig. 1B). Moreover,
formation and remodeling of the fourth pharyngeal arch arteries to
form the aortic arch and right subclavian artery are extremely sensitive
to FGF8 dosage in the pharyngeal ectoderm (Macatee et al., 2003). Con-
sistent with this, we detected retroesophageal right subclavian artery
(RERSC) in one E18.5 NDST1 mutant (Fig. 1D), and double outlet right
ventricle (DORV) was identiﬁed in one out of four E14.5 mutantembryos, indicating that proper alignment and rotation of the OFT
were disrupted or delayed (Table 1). Theseﬁndings provide an explana-
tion for the perinatal lethality of NDST1 null mice, consistent with
cyanosis and respiratory distress observed in NDST1−/− neonates (Fan
et al., 2000; Ringvall et al., 2000).
2.2. NDST1 expression and HS composition in the mouse embryonic heart
Because all 4 NDST isoenzymes contribute to HS synthesis, and be-
causemultiple growth-promoting FGFs bind toHSduring cardiogenesis,
we ﬁrst performed semiquantitative RT-PCR to determine FGF-, FGFR-
and NDST expression in the E14.5-E18.5 embryonic heart (Table 2).
NDST1 was strongly expressed at all stages investigated, whereas
NDST3 and NDST4 mRNA expression was generally weaker or absent.
The HS-binding ﬁbroblast growth factors FGF1, FGF2, FGF8 and FGF9
as well as their receptors were also widely expressed. However, neither
mRNAnor protein expression does strictly predict NDST activity. During
biosynthesis, several HS-synthesizing enzymes form a multienzyme
complex termed the GAGosome (Esko and Selleck, 2002). GAGosome
composition of speciﬁc NDST isoforms can vary depending on their
relative levels of expression or that of other proteins that may act as
chaperones or scaffolding proteins. Therefore, as a functional readout
for NDST1 enzyme activity, heart sections were stained with two differ-
ent HS-speciﬁc antibodies, HepSS1 and 10E4. Both antibodies require
NDST-generated GlcNS to bind HS. HepSS1 antibodies detected HS
localized to various regions of the wildtype embryonic heart, whereas
HS expressed in Ndst1 mutant tissues was not detected (Fig. 2).
Likewise, we found that HS-staining by 10E4 speciﬁcally depended on
NDST1 activity, consistent with previous ﬁndings (Pan et al., 2006;
Pallerla et al., 2007). In E12.5wildtype embryos, 10E4 stained the devel-
oping ventricles and ventricular septae (Fig. 2). 10E4 stainingwas unde-
tectable in corresponding NDST1 null tissue sections.
Next, HS was isolated from E18.5 wildtype and NDST1 mutant em-
bryos for compositional analysis by quantitative mass spectrometry
(Lawrence et al., 2008) (Table 3). Disaccharide analysis revealed strong-
ly increased levels of unsulfated disaccharide D0A0 (68.6% relative
abundance in NDST1−/− derived HS versus 51.5% in wildtype derived
HS). In contrast, the relative abundance of N-sulfated, 2-O sulfated
and 6-O sulfated disaccharides was reduced in the NDST1 null embryo
(24.4% versus 40.7%, 13.7% versus 19.1% and 21.2% versus 23%, re-
spectively). These ﬁndings conﬁrm that deletion of NDST1 affects
O-sulfation in addition to N-sulfation. 10E4 binding to HS requires spe-
ciﬁc N-sulfated andN-acetylated disaccharide units (van den Born et al.,
2005); thus, complete loss of 10E4 binding toNDST1null tissues despite
only moderately reduced N-sulfation conﬁrms speciﬁc, NDST1 depen-
dent synthesis of the 10E4 HS epitope (Pallerla et al., 2007).
2.3. NDST1 is a regulator of FGF function and proliferation in the embryonic
heart
Cell proliferation depends on FGF function, and the NDST ortholog
Sulfateless plays crucial roles in the generation of FGF binding sites
in Drosophila melanogaster (X. Lin et al., 1999) and in cell culture
(Ishihara et al., 1993). FGFs bind and activate alternatively spliced
forms of four tyrosine kinase FGF receptors (FGFRs 1–4) (Zhang et al.,
2006). FGF activity is regulated by spatial and temporal expression pat-
terns of FGFs and FGFRs, and by the regulated formation of speciﬁc
ligand-receptor pairs. FGF ligand-receptor pairing is regulated by their
binding speciﬁcity to HS chains of HSPGs, which in turn depends on
speciﬁc HS sulfation motifs. Thesemotifs are essential for the formation
of signaling-active, trimeric FGF/FGFR/HS complexes. To test for HS-
dependent FGF/FGFR assembly that regulates heart development
starting at E10.5 (Ostrovsky et al., 2002), heart sections were incubated
with FGF and FGFR fused with human IgG Fc domain (FGFR/Fc). Bound
FGFR-Fc was then probed with a ﬂuorescent anti-IgG antibody. In E10.5
wild type embryo sections, we observed FGFR1c, FGFR2b, FGFR2c and
Fig. 1.Heart defects inNDST1mutant E18.5 embryos. A–D) Ventricular septal defect (VSD, arrowhead in B) and retroesophageal right subclavian artery (RERSC, arrowhead in D) in trans-
verse sections generated from E18.5 embryos. VSDwas detected in all 7mutant embryos investigated (Table 1). One embryo showed RERSC. Abbreviations used: lv: left ventricle, rv: right
ventricle, mv: mitral valve, lvot: left ventricular outﬂow tract, rsc: right subclavian artery, rcc: right common carotid, lcc: left common carotid, e: esophagus, tr: trachea, thy: thymus. Size
bars: 0.5 mm.
Table 2
Semiquantitative RT-PCR demonstrates NDST1-NDST4 expression and expression of the
FGFS and their receptors in E14.5-E18.5 mouse embryonic hearts. NDST1 and NDST2 are
robustly expressed at all stages investigated,whereas NDST3 andNDST4 are not expressed
or expressed at lower levels. FGF1, FGF2, FGF8 and FGF9 as well as FGFRS1–4 were all
detected during heart development. +: Strong expression, (+): weak expression, -: no
detectable expression, NA: not assessed. RT-PCR was independently conducted 3–5
255Y. Pan et al. / Matrix Biology 35 (2014) 253–265FGFR3b complex formation with FGF1 on ventricular and atrial tissue
(Fig. 3 and not shown). As a control, no signal was detectable in the ab-
sence of FGF ligand under the same experimental conditions (Supple-
mental material), conﬁrming that the observed FGF/FGFR binding in
situ required cell surface HS. In E10.5 NDST1 null heart sections, FGF1/
FGFR2c formation was reduced (Fig. 3), in contrast, FGF1/FGFR2b and
FGF1/FGFR3b binding was only slightly affected or even unchanged
(not shown). FGF2/FGFR2b and FGF2/FGFR4 binding was strongly
reduced in the mutant, as was binding of FGF8/FGFR2c and FGF9/
FGFR3b pairs. The observed differential binding of speciﬁc FGF/FGFR
pairs thus suggests that NDST1 function is required for the assembly
of some (but not all) FGF-FGFR pairs in heart tissue, including FGF8/
FGFR2c. This is consistent with the observed comparable cardiovascular
phenotypes in NDST1 null embryos and FGF8-deﬁcient hypomorphs.Table 1
Summary of phenotypes observed in systemic and conditional NDST mutant embryos.
VSD: ventricular septal defect, DORV: double outlet right ventricle, PTA: persistent truncus
arteriosus, RERSC: retroesophageal right subclavian artery.
VSD DORV PTA RERSC
WT (E18.5)(n = 5) 0/5 0/5 0/5 0/5
NDST1−/− (E14.5)(n = 4) N/A 1/4 0/4 N/A
NDST1−/− (E18.5)(n = 7) 7/7 0/7 0/7 1/7
NDST2−/− (E18.5)(n = 8) 0/8 0/8 0/8 0/8
WNT1-Cre; NDST1f/f (E18.5)(n = 4) 3/4 0/4 0/4 0/4
WNT1-Cre; NDST1f/f; NDST2−/− (E18.5)(n = 4) 4/4 0/4 4/4 1/4The signiﬁcant loss of FGF-FGFR binding to NDST1-null tissue sug-
gested that FGF signaling was compromised during development. To
test this possibility, we examined the expression of phospho-ERK1/2
(pERK1/2) acting as downstream effectors of the FGF-MAPK pathway.
Using a phospho-speciﬁc antibody against ERK1/2,we detected reduced
ERK1/2 phosphorylation in NDST1−/− E10.5 embryonic hearts (Fig. 4A
and B, and insets), areas that also showed loss of FGF/FGFR pairingtimes on at least two independent cDNA preparations from whole embryonic hearts.
E14.5 E15.5 E16.5 E17.5 E18.5
NDST1 + + + + +
NDST2 N/A + N/A + +
NDST3 (+) (+) (+) - (+)
NDST4 (+) (+) (+) - -
FGF1 + + - + +
FGF2 + + + + +
FGF8 - + + + −
FGF9 + + - + +
FGFR1 + + + + +
FGFR2 + + + + +
FGFR3 + + + + +
FGFR4 + - - + +
Fig. 2.NDST expression in the developing heart. Top:HS detected by themonoclonal anti-HS antibodyHepSS1. Bottom:HSdetected by themonoclonal anti-HS antibody10E4. HepSS1- and
10E4 reactive HS epitopes were widely expressed in developing heart tissues of wildtype embryos (E12.5), but not in NDST mutant embryos. vw: ventricular wall, vs: ventricular septum.
256 Y. Pan et al. / Matrix Biology 35 (2014) 253–265(Fig. 3). Total ERKprotein levelswere unchanged as demonstrated by an
antibody directed against both, phosphorylated and unphosphorylated
ERK (Fig. 4C and D). NDST1-dependent ERK-phosphorylation in the
heart is consistent with its reported loss in NDST1 null eye lenses and
lacrimal glands (Pan et al., 2006, 2008).
To determine whether impaired FGF8 function contributes to re-
duced ERK-phosphorylation in NDST1 deﬁcient cells, ﬁbroblasts were
isolated from wildtype and mutant E14.5 embryos. Cultured cells were
starved from serum for 20 h and then stimulated for 5 min with FGF2
or FGF8 conditioned medium derived from FGF2/FGF8-transfected
Bosc23 cells. Serum was added as a positive control, and DMEM from
mock-transfected Bosc23-cells served as a negative control (Fig. 4E).
ERK1/2 phosphorylationwas strongly stimulated inwildtypeﬁbroblasts
in response to both FGF2 and FGF8. In contrast, ERK1/2 phosphorylation
in NDST1−/− ﬁbroblasts was unchanged in response to FGF2, consistentTable 3
Quantitative disaccharide analysis revealed undersulfation of HS derived from E18.5
NDST1−/− embryos. Numbers denote the relative amounts of detected disaccharides.
WT NDST1−/−
Unsulfated 51.5 68.6
N-sulfated 40.7 24.4
2-O-sulfated 19.1 13.7
6-O-sulfated 23 21.2with previous ﬁndings (Grobe et al., 2005). Notably, FGF8 also failed to
stimulate ERK1/2 phosphorylation. ERK1/2 in NDST1−/− cells was not af-
fected per se, since serum efﬁciently stimulated ERK-phosphorylation.
These ﬁndings indicate that FGF8 coreceptor function of HS expressed
in NDST1−/− embryos is impaired, consistent with reduced HS-
dependent FGF8/FGFR2c assembly observed in this work (Fig. 3).
FGF-induced MAPK-signaling stimulates cell proliferation, and con-
ditional NDST1 mutant mice show impaired vascular smooth muscle
cell proliferation (Adhikari et al., 2010).We thus tested next for possible
changes in cell proliferation in NDST1mutant heart tissue. Cell prolifer-
ation was determined by an antibody that labels cells in G1 and S-phase
(Proliferating Cell Nuclear Antigen, PCNA) in E14.5 mutant animals and
wild-type littermate controls (Supplemental materials). We found that
cell proliferation was indeed signiﬁcantly reduced in the NDST1−/−
ventricular wall (~83% of wildtype levels (31% ± 3% versus 38% ± 3%,
p = 0.101, n = 7)) and in the ventricular septum (~75% of wildtype
levels (41% ± 2% versus 54% ± 2%, p = 0.0028, n = 4)), indicating
that impaired growth factor activity may contribute to proliferation-
related NDST1−/− cardiac phenotypes, such as VSD.
2.4. NDST1 expression and apoptosis in branchial arches
Ablation and genetic studies have shown that NCC production,
delamination, directed migration and survival are critical for cardiovas-
cular development (Gitler et al., 2002). Cardiac defects observed in
NDST1 null embryos are consistent with impaired NCC development,
Fig. 3. NDST1 mutation disrupted FGF/FGFR interaction. LACE-assay detection of FGF/FGFR binding to HS of E10.5 wildtype and NDST−/− coronal heart sections. HS-mediated FGF2/
FGFR2b, FGF2/FGFR4, FGF8/FGFR2c, FGF9/FGFR3b and FGF1/FGFR2c binding were observed in the wildtype heart, often speciﬁcally to endocardium, but were reduced in heart tissue of
NDST1 mutant embryos. vc: ventricular chamber, a: atria. Comparable anatomical structures in wildtype and mutant tissue sections of given FGF/FGFR combinations are indicated by
dashed lines.
257Y. Pan et al. / Matrix Biology 35 (2014) 253–265such as failure of OFT septation and aortic arch artery defects. Impor-
tantly, NCCs require FGF8 function (Abu-Issa et al., 2002; Goddeeris
et al., 2007), and NCCs in FGF8 mutant embryos undergo cell death in
areas both adjacent and distal to the ectoderm and mesenchyme of
the developing pharyngeal arches where FGF8 is normally expressed
(Schneider et al., 2001; Abu-Issa et al., 2002; Frank et al., 2002; Song
et al., 2010). We conﬁrmed NDST1 protein expression (Fig. 5A) and
10E4 reactivity (Fig. 5B) in E10.5 pharyngeal arches, suggesting that
its loss may result in increased NCC apoptosis due to reduced FGF8
activity in these tissues. To test this possibility, TUNEL staining was
conducted in pharyngeal arches and maxillary prominences of E10.5
wildtype and mutant mouse embryos. We detected strongly increased
apoptosis, particularly in pharyngeal pouches that express FGF8 (Song
et al., 2010) and FGFR2 (Zhang et al., 2008) (Fig. 5D, arrows and
inset). Increased apoptosis was also observed in NDST1−/− branchial
arch mesenchyme (ba, Fig. 5F, arrows) and mesenchyme of the de-
velopingmaxillary prominences (m, Fig. 5H, arrow) that both harbor
migrating NCCs. Statistical analysis revealed that the observed increase
of apoptosis in NDST1 null mesenchymal tissue was signiﬁcant
(16% ± 3% of TUNEL positive nuclei relative to total nuclei, versus
6.5% ± 1% in the wildtype (p b 0.05, n = 3 mutant and wildtype
embryos)).
2.5. SHH signaling in the embryonic heart depends on NDST1 expression
SHHmutantmice have atrial septumprimumand septumsecundum
defects, membraneous VSD and defects in valve development
(Washington Smoak et al., 2005) similar to those observed in NDST1
mutants. To understand whether SHH signaling is affected in the
NDST1 mutant heart, we examined the expression of the SHH receptor
Patched1 (PTC1) which reﬂects the extent of SHH signaling as well as
signaling mediated by the other HH family members, Indian hedgehog
and Desert hedgehog. Strong PTC1 expression was detected in all
developing valves in E14.5 wildtype mice (Fig. 6). In the developing
atrioventricular (A) and pulmonary (B) valves (arrows), PTC expression
and thus SHH signaling was restricted to transdifferentiated cells popu-
lating the cardiac cushions, whereas the overlying endothelium strong-
ly expressed 10E4 positive HS. On the other hand, in NDST1 mutant
hearts, remodeling of the cardiac cushions into thinly tapered heart
valves was impaired (Fig. 6C and D, asterisks). PTC expression was
strongly reduced and remaining staining was patchy, and the endothe-
lial expression of 10E4 reactive HS was absent. These data demonstratethat NDST1 contributes toHS sulfation in developing valve endothelium
and also demonstrates that SHH signaling in valves, directly or indirect-
ly, depends on NDST1 function.
Notably, BMP, WNT and TGF-β functions also contribute to heart
development and depend on HS-expression, raising the possibility
that these pathways are impaired in NDST1 null mice. However, previ-
ous analysis demonstrated unaffected BMP/TGF-β and Wnt signaling
in thesemice (Pan et al., 2006). In contrast, FGF/FGFR and SHH signaling
was strongly impaired in various developingNDST1−/− cells and tissues
(Grobe et al., 2005; Pan et al., 2006; Fuster et al., 2007; Pan et al., 2008;
Lanner et al., 2010; Qu et al., 2011, 2012). Thus, we suggest that FGF/
FGFR function, and directly/indirectly HS-linked SHH signaling, most
obviously depend on NDST1 expression during heart development.
2.6. Conditional NDST1 ablation in NCCs also results in developmental
heart defects
To test for a possible role of NCC-autonomous HS expression, we
employed WNT1-Cre recombinase expression (Brault et al., 2001) to
speciﬁcally disrupt NDST1 function in these cells. It has previously
been shown that WNT1-Cre driven deletion of EXT1 function resulted
in striking craniofacial and cardiac defects (Iwao et al., 2009). Consistent
with this, WNT1-Cre; NDST1f/f embryos survived to term with high
incidence of VSD (n = 3 out of 4) (Fig. 7B, compare to Fig. 7A)
(Table 1). However, OFT defects were not detected in these embryos,
possibly due to the compensatory activity of other NDST family mem-
bers. NDST2 compensates for the loss of NDST1 function in various
systems (Grobe et al., 2002), and HS N-sulfation is completely lost in
cells lacking NDST1 and NDST2 gene function (Holmborn et al., 2004).
Consistent with this, WNT1-Cre mediated disruption of NDST1 gene
function in a NDST2 deﬁcient background (WNT1-Cre; NDST1f/f;
NDST2−/−) accentuates the observed defects, resulting in E14.5 hypo-
plastic heartswith thinned ventricularwalls and large ventricular septal
defects (n = 4 out of 4) (Fig. 7C). Fully penetrant PTA and a complete
failure of OFT septation into the aorta and pulmonary artery were also
observed (Fig. 7F, compare to Fig. 7D and E). These defects disrupt the
partitioning of blood ﬂow required for adequate oxygenation and are
thus lethal. RERSCwas observed in one of four E14.5 compoundmutant
embryos (Fig. 7I). None of these defects were observed in NDST2 null
(control) embryos (n = 8), consistent with their postnatal survival
(Forsberg et al., 1999). Thus, we conclude that cell autonomous NDST1
expression is absolutely required for CNC function, and demonstrate
Fig. 4. Loss of FGF signaling in NDST1−/− ventricular septa. A, B) Speciﬁc pERK staining was detected in ventricle of E10.5 NDST1 mutant and wildtype embryos (brown stain, arrows).
InNDST1mutant littermates, pERK detectionwas reduced (arrows). Inset:magniﬁcation of pERK reactive cell clusters. Three embryos of each genotypewere analyzed, one representative
result is shown. C, D) Antibodies directed against phosphorylated and unphosphorylated (total) ERK proteins stained both tissue sections at comparable levels. Four embryos of each ge-
notype were analyzed, one representative result is shown. E) FGF2- and FGF8-dependent ERK1/2 phosphorylation is signiﬁcantly reduced in NDST1 mutant embryonic ﬁbroblasts. Cul-
tured cells derived from E14.5 wildtype and mutant littermates were stimulated with 10% serum in DMEM or FGF2/8 conditioned DMEM for 5 min before analysis. Phosphorylation of
ERK1 and ERK2 (pERK1 and pERK2) was observed in thewildtype after addition of FGF2, FGF8 or serum, however, FGF addition failed to stimulate ERK1/2 phosphorylation in NDST1mu-
tant cells. n = 2 (FGF2) and n = 3 (FGF8). - refers to no stimulation.
258 Y. Pan et al. / Matrix Biology 35 (2014) 253–265that heart defects observed in systemic NDST1−/− embryos can be
explained, in large part, by impaired HS-dependent NCC development.
2.7. Lack of NCC speciﬁc NDST1 expression results in decreased MAPK
signaling and increased apoptosis
Comparable cardiac phenotypes in systemic and conditional NCC-
speciﬁc NDST null embryos imply comparable underlying mechanisms,
such as increased apoptosis and decreasedMAPK signaling and prolifer-
ation in tissues populated by the NCC. Indeed, as shown in Fig. 8B,
microscopic analysis of WNT1-Cre; NDST1f/f; NDST2−/− branchial
arches showed strongly decreased pERK staining in 10E4-negative
mesenchymal tissue (Fig. 8D and F, compare to 10E4-binding (red) in
C, E). In contrast, epithelial cells in conditional mutant embryos showed
unimpaired ERK-phosphorylation (Fig. 8A and B, arrows). Apoptosis in
10E4 negative, NDST1/NDST2 compound null mesenchyme increased
from 2.4% ± 0.75% of total cells (NDST2−/−, n = 14) to 11.45% ± 4%(WNT1-Cre; NDST1f/f; NDST2−/−, n = 11, p b 0.05) (Fig. 8G). This
indicates that NDST1-dependent HS sulfation positively regulates cell
survival. These data, taken together with the observed comparable
cardiac phenotypes of WNT1-Cre; NDST1f/f; NDST2−/− and systemic
NDST1−/− embryos, demonstrate that NCC-autonomous NDST1/HS
expression is required for normal cardiac development. Undersulfation
of NCC-expressed HS is associated with reduced MAPK signaling and
increased cell death in branchial arch mesenchyme: both processes
may contribute to the observed cardiac defects.
3. Discussion
NDST1 null mice die perinatally/neonatally with a condition re-
sembling respiratory distress syndrome in premature human infants
(Ringvall et al., 2000) and show severe developmental defects of the
skull, face and eyes due to impaired function of various HS-binding
growth factors and morphogens (Fan et al., 2000; Ringvall et al., 2000;
Fig. 5.NDST expression, HS expression, and apoptosis in branchial arch tissue. A) Immunohistochemical analysis using afﬁnity puriﬁed rabbit-anti-mouse antiserum raised againstmurine
NDST1 (left). NDST1 protein is strongly expressed (brown stain) and is also biosynthetically active, as demonstrated by 10E4 reactivity of pharyngeal arch HS (B, green stain). Preimmune
sera or secondary antibodies alone did not result in detectable staining (not shown). 1–3: ﬁrst to third pharyngeal arches. C–H: Apoptosis is signiﬁcantly enhanced in branchial arches of
NDST1 mutant embryos. (D) TUNEL staining reveals locally increased cell death (green nuclei) in the ﬁrst branchial cleft (arrows) of E10.5 NDST1−/− embryos. Inset: Magniﬁcation of
TUNEL positive clusters shown in D. ba1: First branchial arch. E, F) NDST1 deﬁcient branchial arch mesenchyme also undergoes increased programmed cell death (arrows) if compared
to wildtype branchial arch mesenchyme. G,H) Mesenchyme of the maxillary prominences likewise show increased programmed cell death in mutant embryos (H, arrow) if compared
to wild type tissue (G, arrow). m: mesenchymal tissue. Five sections of each, three wildtype and three mutant embryos were analyzed.
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In this work, we characterized cardiovascular development in these
mice, conﬁrming previous studies implicating essential functions of
glycosaminoglycans and proteoglycans in heart development (Ng
et al., 2009; Adhikari et al., 2010; Iwamoto et al., 2010; Baasanjav
et al., 2011). Strikingly, targeted disruption of NCC-autonomous HS
synthesis resulted in the same malformations observed in systemicNDST1−/− embryos; this demonstrates an essential role of NDST1-
modiﬁed HS for NCC function during cardiogenesis. This is consistent
with experimental or genetic ablation of NCC development in other sys-
tems that also result in cardiovascular abnormalities. Moreover, human
birth defect syndromes based on defective NCCdevelopment (Kirby and
Waldo, 1995; Maschhoff and Baldwin, 2000; Lindsay, 2001) are often
associated with craniofacial ﬁndings also seen in NDST1 mutant mice,
Fig. 6. Altered HS structure and loss of Ptc expression in NDST1 mutant valves. A–D) Sulfated HS expression recognized by 10E4 antibodies in wildtype valves (A, B, arrows, green
ﬂuorescence) is lost in E18.5 NDST1 mutant atrioventricular (C) and pulmonary (D) valve endothelia. PTC protein was expressed in wildtype valve cushion (A, B, red ﬂuorescence) but
undetectable in mutant valves (C, D, asterisks), indicating impaired SHH signaling in those structures. Also note malformation of the atrioventricular valve due to thickened cushions
(asterisks). Representative results of three mutant and wildtype hearts are shown.
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prominences and defects of the viscerocraniumand neurocranium. SHH
deﬁcient mice have enhanced death of migrating NCCs that give rise to
much of the skull and the face, resulting in severe craniofacial defects
similar to those seen in NDST1 mutant embryos (Washington Smoak
et al., 2005). SHH deﬁcient embryos, and conditional Smoothened (a
transmembrane protein thatmediates intracellular HH effects)mutants
(Lin et al., 2006) also have ventricular septal defects and atrioventricular
valve defects as found in NDST1 mutant embryos. These ﬁndings
indicate that impaired SHH function may contribute not only to facial
defects (Grobe et al., 2005) but also to defects in NDST1−/− embryonic
heart and valve development. This possibility is supported by reduced
SHH mRNA expression and signaling as a consequence of impaired
GLP3 function as a co-receptor for FGF9 (Ng et al., 2009), a growth factor
also affected in the NDST1−/− embryonic heart (Fig. 3). Notably, GLP3
loss-of-function mutations in humans cause Simpson–Golabi–Behmel
syndrome, a complex overgrowth syndrome also associated with con-
genital heart disease (A.E. Lin et al., 1999).
Multiple signaling molecules bind to HS and trigger cardiomyocyte
differentiation or guide the formation of cardiac substructures, includ-
ing WNT, BMP/TGF-β, HB-EGF (Brand, 2003; Andelﬁnger, 2008;
Filmus et al., 2008; Iwamoto et al., 2010) and FGF family members
(Sanford et al., 1997; Abu-Issa et al., 2002; Frank et al., 2002; Delot
et al., 2003; Armstrong and Bischoff, 2004; Liu et al., 2004; Park et al.,
2008). However, previous analysis demonstrated unaffected BMP/TGF-
β and Wnt signaling in NDST1−/− embryos (Pan et al., 2006; Pallerla
et al., 2007), suggesting that these proteins do not depend on NDST1
activity. In contrast, FGF/FGFR signaling was strongly impaired in nu-
merous NDST1-deﬁcient tissues or cells (Grobe et al., 2005; Pan et al.,
2006; Fuster et al., 2007; Pan et al., 2008; Lanner et al., 2010; Qu et al.,
2011, 2012). Consistent with this, we noticed that VSDs and OFT align-
ment defects in NDST1 mutant embryos closely resemble those com-
monly seen in FGF8 hypomorphs and tissue restricted conditional
FGF8 mutants (Abu-Issa et al., 2002; Frank et al., 2002; Macatee et al.,
2003; Moon et al., 2006; Park et al., 2006). In addition, FGF8 mutantsshare neural, limb and craniofacial defects similar to those found in
NDST1 null embryos. This indicates that FGF8 function is impaired in
NDST1 null mice, consistent with reduced ERK-phosphorylation upon
FGF8-stimulation in NDST1−/− derived ﬁbroblasts. Furthermore, RERSC
detected in systemic NDST1−/− mutants and NCC-speciﬁc WNT1-Cre;
NDST1f/f; NDST2−/− mutants is common in FGF8 hypomorphic mice
and pharyngeal ectoderm conditional FGF8 mutants (Macatee et al.,
2003). Consistentwith the proposed role of HS in NCC function discussed
above, and the proposed role of NDST1 function in FGF8 activity regula-
tion, cardiovascular defects in FGF8 mutants have been linked to im-
paired development of NCCs (Meyers et al., 1998; Abu-Issa et al., 2002;
Macatee et al., 2003). NDST1−/− phenotypes also resemble those found
in FGFR mutant mice (Park et al., 2008). However, although ERK-
phosphorylation is required in NCCs for normal heart and aortic arch de-
velopment, NCCs are not direct targets of FGF8 signaling (Park et al.,
2008).
NCC-speciﬁc deletion of NDST1 function in a systemic NDST2 back-
ground (WNT1-Cre; NDST1f/f; NDST2−/−) resulted in increased severity
of all observed heart defects. WNT1-Cre; NDST1f/f; NDST2−/− mice
showed large VSDs in addition to 100% penetrant PTA, whereas
WNT1-Cre; NDST1f/fmicewere less severely affected. Increased severity
of heart defects in compound mutants corresponds with the reported
effect of increased NCC ablation (Porras and Brown, 2008) that may be
based on further reduced HS sulfation in compound mutants in our
system (Grobe et al., 2002). Notably, in compound NDST1/NDST2 de-
ﬁcient NCCs, signaling by BMP/TGFβ (Iwao et al., 2009) may be affect-
ed as well. BMP/TGFβ depends on HS expression (Hacker et al., 2005;
Hu et al., 2009) and contributes to cardiogenesis (Park et al., 2008).
Thus, in addition to FGF signaling, we suggest that BMP and TGFβ
function may also be affected in WNT1-Cre; NDST1f/f; NDST2−/−
NCCs, resulting in more strongly affected OFT remodeling. In humans,
this impaired ability of mutant HS to bindmultiple soluble cardiogenic
molecules, including but not restricted to FGFs, may thus contribute to
congenital heart defect syndromes that affect nearly 1% of human
newborns.
Fig. 7.Neural crest cell speciﬁc knockout of NDST1 results in VSD and OFT defects. Tissue speciﬁc deletion of NDST1 inNCCs using E14.5WNT1-Cre; NDST1ﬂox/ﬂox (n = 4) andWNT1-Cre;
NDST1ﬂox/ﬂox; NDST2−/− double mutants (n = 4) results in severe heart defects. A–C) VSD was detected in single and double mutants, but defects were more severe in the compound
mutant, indicating compensatory activity of NDST2. Of four WNT1-Cre; NDST1ﬂox/ﬂox and four WNT1-Cre; NDST1ﬂox/ﬂox; NDST2−/− compound mutants, all had large VSDs (arrow).
D–F) In NDST1/2 compound mutants (WNT1-Cre; NDST1ﬂox/ﬂox; NDST2−/−), severe outﬂow tract defects such as PTA were also observed in four out of four embryos investigated.
e: esophagus, tr: trachea, aao: ascending aorta, dao: descending aorta, rv: right ventricle, pt: pulmonary trunc, TA: truncus arteriosus. G–I) Of four WNT1-Cre; NDST1ﬂox/ﬂox; NDST2
−/− embryos investigated, one had retroesophageal right subclavian artery (RERSC, arrow). thy: thymus, rsc: right subclavian artery, rcc: right common carotid.
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4.1. Mice
The generation of theNDST1− allele and ofWNT1-Cremice has been
described previously (Brault et al., 2001; Grobe et al., 2005).
4.2. Histology and detection of mRNA expression
Embryos were ﬁxed in 4% paraformaldehyde overnight, dehydrated,
embedded in parafﬁn and sectioned at 8 μm. Sectionswere stainedwith
haematoxylin and eosin for histological analysis. For immunohisto-
chemical analysis, hearts were quick-frozen in prechilled isopentane
and embedded in Tissue-Tec (Leica Instruments, Wetzlar, Germany).
Hearts were cryotome-sectioned to 12 μm slices. Sections were rinsed
with PBS and permeabilized for 5–10 min in PBS supplemented with
0.1% Triton-X100 and blocked in 10% fetal calf serum/1% bovine serum
albumin for 1–2 h.
4.3. Immunohistochemistry
For immunohistochemical HS detection, mouse monoclonal anti-
bodies HepSS1 and 10E4 (Seikagaku, Tokyo, Japan) were used at a
1:100 dilution in PBS/5% milk powder at 4 °C overnight. 10E4 recog-
nizes a HS epitope speciﬁcally generated by NDST1 activity, serving
as a readout for enzyme activity (Pan et al., 2006; Pallerla et al.,
2007). Prior to antibody incubation, epitope retrieval was performedby boiling slides in 0.1 M sodium citrate, pH6.0, for 20 min, followed
by three washing steps in PBS. Control slides were heparinase I–III
digested (Ibex, Montreal, Canada) (50 mM Hepes, 100 mM NaCl,
1 mMCaCl2, 5 μg BSA/ml, pH 7.0) for 1 h at 37 °C to conﬁrm antibody
speciﬁcity. After antibody incubation, slides were washed three times
for 10 min each in PBS prior to incubation with secondary Alexa- or
FITC-labeled α-IgG/IgM H + L antibody (1:200, Jackson Immuno-
Research, West Grove, USA). Immunohistochemical analysis of
NDST1 expression was performed using afﬁnity-puriﬁed anti-NDST
antiserum (Grobe and Esko, 2002) followed by detection with goat
anti-rabbit HRP conjugated antibodies (Zymed, San Francisco, USA).
Proliferation was quantiﬁed by using α-PCNA antibodies (1:1000,
abcam). TUNEL assays were performed using the In Situ Cell Death
Detection Kit (Roche, Mannheim, Germany) according to the manu-
facturer's instructions. Total ERK and phospho-ERK (pERK) reactivity
as a readout for MAPK activity in tissues and ﬁbroblasts was assessed
by α-phospho-ERK1/2 and α-ERK1/2 antibodies (1:1000, Anti-
active MAPK family sampler, Promega) on frozen sections andWest-
ern blots of SDS-PAGE separated ﬁbroblast cell lysates. Statistical
analysis was performed in Prism using Student's t-test (Two-tailed,
unpaired). All values shown in text and ﬁgures are ± SD. FGF2 and
FGF8 (Accession numbers AI158649 and BC048734) were cloned
into pWIZ (Gene Therapy Systems, San Diego), expressed in Bosc23
cells and secreted into serum-free medium which was subsequently
added to the ﬁbroblasts. Heparin afﬁnity puriﬁcation was employed,
showing elution at 0.8 M salt and thus strong FGF/heparin interac-
tions (not shown).
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Whole E18.5 embryos were digested overnight with 2 mg/ml
pronase in 320 mM NaCl, 100 mM sodium acetate (pH 5.5) at 40 °C,diluted 1:3 in water and applied to 2.5 ml DEAE sephacel columns.
GAGs were applied to PD-10 (Sephadex G25) columns (Pharmacia).
GAGs were lyophilized, Chondroitinase ABC-digested over night, puri-
ﬁed on DEAE as described above, applied to PD-10 columns and again
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using Heparin-lyases I, II and III (1.5 mU of each in 100μl reactions)
(IBEX, Montreal, Canada) at 37 °C for 1 h and the resulting disaccha-
rides were separated from undigested material using a 3 kDa spin-
column (Centricon, Bedford, USA). Compositional disaccharide analysis
of cell-derived HS or HS derived from embryos was then carried out by
liquid chromatography/mass spectrometry (LC/MS) (Lawrence et al.,
2008). Analysis of the disaccharide composition by post-column deriv-
atization with 2-cyanoacetamide or by the LC/MS method gave com-
parable results, and comparison of the two methods using 0.5 μg
commercial porcine heparin showed an error of 2% for abundant disac-
charides to 20% for minor species.
4.5. FGF ligand and carbohydrate engagement assay (LACE)
In situ binding of the FGF-FGFR complex with heparan sulfate was
carried out using the LACE assay as previously described (Pan et al.,
2006). Embryos (E10.5) were harvested and ﬁxed in 4% PFA at 4 °C
overnight prior to parafﬁn embedding. Deparafﬁnized and rehydrated
5 μm sections were incubated with 0.5 mg/ml NaBH4 for 10 min, in
0.1 M glycine for 30 min and blocked with 2% BSA. The slides were
then incubated with 20 μM FGF and 20 μM human FGFR-Fc chimera
(R&D Systems) in RPMI-1640 medium/15% fetal bovine serum at 4 °C
overnight, followed by 2 h incubation at room temperature with Cy-3
labeled anti-human Fc IgG secondary antibody. As a control, FGFR-Fc in
the absence of ligand was added to the slides. Slides were washed in PBS
before mounting and analysis. Images were taken on a Zeiss Axiophot
microscope employing a 10×/0.3, a 20×/0.5 and a 63×/1.25 Zeiss objec-
tive and a Leica DFC280 camera. Also, a Leica inverted microscope
(DMIRB) equipped with a cooled MicroMax CCD camera (Princeton
Instruments, Stanford, USA) was used, employing 5×/0.15, 10×/0.3
and 20×/0.5 Leica objectives. Leica software was used for image captur-
ing and Photoshop 7 software run on MacIntosh computers for the
generation of ﬁgures. Contrast and brightness were adjusted for whole
images during ﬁgure assembly.
4.6. RT-PCR analysis of mRNA expression
For RT-PCR analysis ofmRNAderived fromwildtypehearts, RNAwas
isolated using TriZol reagent (Invitrogen) according to the manufac-
turer's instructions. cDNA was produced employing the First Strand
cDNA Synthesis Kit (Fermentas, Burlington, Canada) according to
the manufacturer's instructions and used as a PCR template under
the following conditions: 1/10 of cDNA (derived from 1 μg total RNA),
hot start for 5 min, 94 °C for 20 s, 59 °C for 30 s, and 72 °C for 2 min,
30 cycles. For the speciﬁc ampliﬁcation of mNDST1-4, eight speciﬁc,
intron-spanning primers (Tm = 62 °C) were used: mNDST1-F(5′-cttg
agccctcggcagatgc-3′) and -R(5′-ccagggtactcgttgtagaag-3′), mNDST2-F
(5′-aggaacccttgcctctgccc-3′) and -R (5′-gatcgtgtgggtgaagaggc-3′),
mNDST3-F (5′-gaaagtgaagtctctgggcgg-3′) and -R (5′-tccgtgaatactcttgtc
cag-3′), mNDST4-F (5′-aacaggaaatgacacttattgaaacg-3′) and -R (5′-aggt
gtataagccgaggcgg-3′). For speciﬁc ampliﬁcation of FGFs/FGFRs, eight in-
tron spanning primers were used: mFGF1-F (5′-agatcacaaccttcgcagcc-
3′) and -R (5′-caatttggtccctgtgttcc-3′), mFGF2-F (5′-atggctgccagcggca
tca-3′) and -R (5′-tcagctcttagcagacattgg-3′), mFGF8-F (5′-cgagctgcctg
ctgttgca-3′) and -R (5′-tgtagagacctgtctctgcg-3′) and mFGF9-F (5′-agt
gctcccttaggtgaagt-3′) and -R (5′-actttgtcagggtccactgg-3′). For speciﬁc
ampliﬁcation of FGFRs, eight intron spanning primers were used:Fig. 8. Reduced ERK-phosphorylation and increased apoptosis upon neural crest cell speciﬁc
double mutants resulted in the loss of ERK phosphorylation in maxillary prominences, indic
ERK-phosphorylation was unaffected in epithelial cells (arrows). C–F) Loss of mesenchymal 10
compound mutant embryos. G) Quantiﬁcation of cell death shown in C–F. Apoptosis is strong
in the wildtype (p b 0.05, n = 2 mutant and wildtype embryos, 11 (mutant) and 14 slides (w
nuclei relative to total nuclei (DAPI-stained) in the entire branchial arch. Twenty sections of ea
of a representative E10.5 embryo, showing maxillary (ba1 max) and mandibular (ba1 man) c
(midbrain) ventricle, vc: ventricular chamber.mFGFR1-F (5′-tggagttcatgtgcaaggtg-3′) and -R (5′-atagagaggaccatcc
tgtg-3′), mFGFR2-F (5′-aaataccaaatctcccaacc-3′) and -R (5′-gccgcttctc
catcttct-3′), mFGFR3-F (5′-actgtactcaagactgcagg-3′) and -R (5′-gtccttg
tcagtcgcatcat-3′) and FGFR4-F (5′-ctgttgagcatctttcaggg-3′) and -R (5′-
cgtggaaggcctgtccatcc-3′).
Acknowledgments
The authors would like to thank Andrea Powers (Indiana University,
Indianapolis, USA) and Amy Talbot (University of Utah, Salt Lake City,
USA) for histological work.
Author roles: Study design: AMM, XZ, KG; Study conduct: YP, CC,
SK, UP, SO,MF, RS, SRR, RL; Data collection: AMM, XZ, KG; Data analysis:
AMM, XZ, KG, Data interpretation: AMM, XZ, KG, Drafting manuscript
AMM, JDE, XZ, KG. KG takes responsibility for the integrity of the data
analysis.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.matbio.2013.10.013.
References
Abu-Issa, R., Smyth, G., Smoak, I., Yamamura, K., Meyers, E.N., 2002. Fgf8 is required for
pharyngeal arch and cardiovascular development in the mouse. Development 129,
4613–4625.
Adhikari, N., Basi, D.L., Townsend, D., Rusch, M., Mariash, A., Mullegama, S., Watson, A.,
Larson, J., Tan, S., Lerman, B., Esko, J.D., Selleck, S.B., Hall, J.L., 2010. Heparan sulfate
Ndst1 regulates vascular smoothmuscle cell proliferation, vessel size and vascular re-
modeling. J. Mol. Cell. Cardiol. 49, 287–293.
Andelﬁnger, G., 2008. Genetic factors in congenital heart malformation. Clin. Genet. 73,
516–527.
Armstrong, E.J., Bischoff, J., 2004. Heart valve development: endothelial cell signaling and
differentiation. Circ. Res. 95, 459–470.
Baasanjav, S., Al-Gazali, L., Hashiguchi, T., Mizumoto, S., Fischer, B., Horn, D., Seelow, D.,
Ali, B.R., Aziz, S.A., Langer, R., Saleh, A.A., Becker, C., Nurnberg, G., Cantagrel, V.,
Gleeson, J.G., Gomez, D., Michel, J.B., Stricker, S., Lindner, T.H., Nurnberg, P.,
Sugahara, K., Mundlos, S., Hoffmann, K., 2011. Faulty initiation of proteoglycan
synthesis causes cardiac and joint defects. Am. J. Hum. Genet. 89, 15–27.
Brand, T., 2003. Heart development: molecular insights into cardiac speciﬁcation and
early morphogenesis. Dev. Biol. 258, 1–19.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMahon, A.P., Sommer, L.,
Boussadia, O., Kemler, R., 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-
mediated deletion results in dramatic brain malformation and failure of craniofacial
development. Development 128, 1253–1264.
Bullock, S.L., Fletcher, J.M., Beddington, R.S.P., Wilson, V.A., 1998. Renal agenesis in mice
homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-
sulfotransferase. Genes Dev. 12, 1894–1906.
Cano-Gauci, D.F., Song, H.H., Yang, H., McKerlie, C., Choo, B., Shi, W., Pullano, R., Piscione,
T.D., Grisaru, S., Soon, S., Sedlackova, L., Tanswell, A.K., Mak, T.W., Yeger, H.,
Lockwood, G.A., Rosenblum, N.D., Filmus, J., 1999. Glypican-3-deﬁcient mice exhibit
developmental overgrowth and some of the abnormalities typical of Simpson–
Golabi–Behmel syndrome. J. Cell Biol. 146, 255–264.
Colvin, J.S., Feldman, B., Nadeau, J.H., Goldfarb, M., Ornitz, D.M., 1999. Genomic organiza-
tion and embryonic expression of the mouse ﬁbroblast growth factor 9 gene. Dev.
Dyn. 216, 72–88.
Costell, M., Carmona, R., Gustafsson, E., Gonzalez-Iriarte, M., Fassler, R., Munoz-Chapuli, R.,
2002. Hyperplastic conotruncal endocardial cushions and transposition of great arter-
ies in perlecan-null mice. Circ. Res. 91, 158–164.
Dell'Era, P., Ronca, R., Coco, L., Nicoli, S., Metra, M., Presta, M., 2003. Fibroblast growth
factor receptor-1 is essential for in vitro cardiomyocyte development. Circ. Res. 93,
414–420.
Delot, E.C., Bahamonde, M.E., Zhao, M., Lyons, K.M., 2003. BMP signaling is required for
septation of the outﬂow tract of the mammalian heart. Development 130, 209–220.
Esko, J.D., Lindahl, U., 2001. Molecular diversity of heparan sulfate. J. Clin. Invest. 108,
169–173.deletion of NDSTs. A, B) Tissue speciﬁc deletion of WNT1-Cre; NDST1ﬂox/ﬂox; NDST2−/−
ating strongly affected HS sulfation and FGF signaling in the mesenchyme. In contrast,
E4 staining (red) and increased apoptosis (green) in ﬁrst branchial arch mesenchyme of
ly increased in compound mutant tissue (NDST1−/−: 11.45% ± 4% versus 2.4% ± 0.75%
ildtype) were analyzed, respectively). Numbers denote the percentage of TUNEL positive
ch, two wildtype and twomutant embryos were analyzed. H) H&E stained frontal section
omponents of the ﬁrst branchial arch, as analyzed in A–G. Abbreviations used: 3rd: third
264 Y. Pan et al. / Matrix Biology 35 (2014) 253–265Esko, J.D., Selleck, S.B., 2002. Order out of chaos: assembly of ligand binding sites in hep-
aran sulfate. Annu. Rev. Biochem. 71, 435–471.
Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B., Hu, G., 2000. Targeted disruption of NDST-1
gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS
Lett. 467, 7–11.
Filmus, J., Capurro, M., Rast, J., 2008. Glypicans. Genome Biol. 9, 224.
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-
Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., Kjellén, L., 1999. Abnormal mast cells
in mice deﬁcient in a heparin-synthesizing enzyme. Nature 400, 773–776.
Frank, D.U., Fotheringham, L.K., Brewer, J.A., Muglia, L.J., Tristani-Firouzi, M., Capecchi,
M.R., Moon, A.M., 2002. An Fgf8 mouse mutant phenocopies human 22q11 deletion
syndrome. Development 129, 4591–4603.
Fuster, M.M., Wang, L., Castagnola, J., Sikora, L., Reddi, K., Lee, P.H., Radek, K.A., Schuksz, M.,
Bishop, J.R., Gallo, R.L., Sriramarao, P., Esko, J.D., 2007. Genetic alteration of endothelial
heparan sulfate selectively inhibits tumor angiogenesis. J. Cell Biol. 177, 539–549.
Gitler, A.D., Brown, C.B., Kochilas, L., Li, J., Epstein, J.A., 2002. Neural crest migration and
mouse models of congenital heart disease. Cold Spring Harb. Symp. Quant. Biol. 67,
57–62.
Goddeeris, M.M., Schwartz, R., Klingensmith, J., Meyers, E.N., 2007. Independent require-
ments for Hedgehog signaling by both the anterior heart ﬁeld and neural crest cells
for outﬂow tract development. Development 134, 1593–1604.
Grobe, K., Esko, J.D., 2002. Regulated translation of heparan sulfate N-acetylglucosamine
N-deacetylase/N-sulfotransferase isozymes by structured 5′-untranslated regions
and internal ribosome entry sites. J. Biol. Chem. 277, 30699–30706.
Grobe, K., Ledin, J., Ringvall, M., Holborn, K., Forsberg, E., Esko, J.D., Kjellen, L., 2002. Hep-
aran sulfate and development: differential roles of the N-acetylglucosamine N-
deacetylase/N-sulfotransferase (NDST) isozymes. Biochim. Biophys. Acta 1573,
209–215.
Grobe, K., Inatani, M., Pallerla, S.R., Castagnola, J., Yamaguchi, Y., Esko, J.D., 2005. Cerebral
hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene func-
tion. Development 132, 3777–3786.
Hacker, U., Nybakken, K., Perrimon, N., 2005. Heparan sulphate proteoglycans: the sweet
side of development. Nat. Rev. Mol. Cell Biol. 6, 530–541.
Holmborn, K., Ledin, J., Smeds, E., Eriksson, I., Kusche-Gullberg, M., Kjellen, L., 2004.
Heparan sulfate synthesized by mouse embryonic stem cells deﬁcient in NDST1
and NDST2 is 6-O-sulfated but contains no N-sulfate groups. J. Biol. Chem. 279,
42355–42358.
Hotta, Y., Sasaki, S., Konishi, M., Kinoshita, H., Kuwahara, K., Nakao, K., Itoh, N., 2008. Fgf16
is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev. Dyn.
237, 2947–2954.
Hu, Z., Wang, C., Xiao, Y., Sheng, N., Chen, Y., Xu, Y., Zhang, L., Mo,W., Jing, N., Hu, G., 2009.
NDST1-dependent heparan sulfate regulates BMP signaling and internalization in
lung development. J. Cell Sci. 122, 1145–1154.
Inatani, M., Irie, F., Plump, A.S., Tessier-Lavigne, M., Yamaguchi, Y., 2003. Mammalian
brain morphogenesis and midline axon guidance require heparan sulfate. Science
302, 1044–1046.
Ishihara, M., Guo, Y., Wei, Z., Yang, Z., Swiedler, S.J., Orellana, A., Hirschberg, C.B., 1993.
Regulation of biosynthesis of the basic ﬁbroblast growth factor binding domains of
heparan sulfate by heparan sulfate-N-deacetylase/N-sulfotransferase expression.
J. Biol. Chem. 268, 20091–20095.
Iwamoto, R., Mine, N., Kawaguchi, T., Minami, S., Saeki, K., Mekada, E., 2010. HB-EGF func-
tion in cardiac valve development requires interaction with heparan sulfate proteo-
glycans. Development 137, 2205–2214.
Iwao, K., Inatani, M., Matsumoto, Y., Ogata-Iwao, M., Takihara, Y., Irie, F., Yamaguchi, Y.,
Okinami, S., Tanihara, H., 2009. Heparan sulfate deﬁciency leads to Peters anomaly
inmice by disturbing neural crest TGF-beta2 signaling. J. Clin. Invest. 119, 1997–2008.
Kirby, M.L., Waldo, K.L., 1995. Neural crest and cardiovascular patterning. Circ. Res. 77,
211–215.
Kuratani, S.C., Kirby, M.L., 1992. Migration and distribution of circumpharyngeal crest
cells in the chick embryo. Formation of the circumpharyngeal ridge and E/C8+
crest cells in the vertebrate head region. Anat. Rec. 234, 263–280.
Lanner, F., Lee, K.L., Sohl, M., Holmborn, K., Yang, H., Wilbertz, J., Poellinger, L., Rossant, J.,
Farnebo, F., 2010. Heparan sulfation-dependent ﬁbroblast growth factor signaling
maintains embryonic stem cells primed for differentiation in a heterogeneous state.
Stem Cells 28, 191–200.
Lavine, K.J., Yu, K., White, A.C., Zhang, X., Smith, C., Partanen, J., Ornitz, D.M., 2005.
Endocardial and epicardial derived FGF signals regulate myocardial proliferation
and differentiation in vivo. Dev. Cell 8, 85–95.
Lawrence, R., Olson, S.K., Steele, R.E., Wang, L., Warrior, R., Cummings, R.D., Esko, J.D.,
2008. Evolutionary differences in glycosaminoglycan ﬁne structure detected by quan-
titative glycan reductive isotope labeling. J. Biol. Chem. 283, 33674–33684.
Li, J.P., Gong, F., Hagner-McWhirter, A., Forsberg, E., Abrink, M., Kisilevsky, R., Zhang, X.,
Lindahl, U., 2003. Targeted disruption of a murine glucuronyl C5-epimerase gene re-
sults in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J. Biol. Chem.
278, 28363–28366.
Lin, A.E., Neri, G., Hughes-Benzie, R., Weksberg, R., 1999a. Cardiac anomalies in the
Simpson–Golabi–Behmel syndrome. Am. J. Med. Genet. 83, 378–381.
Lin, X., Buff, E.M., Perrimon, N., Michelson, A.M., 1999b. Heparan sulfate proteoglycans are
essential for FGF receptor signaling during Drosophila embryonic development.
Development 126, 3715–3723.
Lin, L., Bu, L., Cai, C.L., Zhang, X., Evans, S., 2006. Isl1 is upstream of sonic hedgehog in a
pathway required for cardiac morphogenesis. Dev. Biol. 296, 756–763.
Lindahl, U., Kusche-Gullberg, M., Kjellén, L., 1998. Regulated diversity of heparan sulfate.
J. Biol. Chem. 273, 24979–24982.
Lindsay, E.A., 2001. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat.
Rev. Genet. 2, 858–868.Liu, W., Selever, J., Wang, D., Lu, M.F., Moses, K.A., Schwartz, R.J., Martin, J.F., 2004. Bmp4
signaling is required for outﬂow-tract septation and branchial-arch artery remodel-
ing. Proc. Natl. Acad. Sci. U. S. A. 101, 4489–4494.
Macatee, T.L., Hammond, B.P., Arenkiel, B.R., Francis, L., Frank, D.U., Moon, A.M., 2003.
Ablation of speciﬁc expression domains reveals discrete functions of ectoderm- and
endoderm-derived FGF8 during cardiovascular and pharyngeal development. Devel-
opment 130, 6361–6374.
Maschhoff, K.L., Baldwin, H.S., 2000. Molecular determinants of neural crest migration.
Am. J. Med. Genet. 97, 280–288.
McLaughlin, D., Karlsson, F., Tian, N., Pratt, T., Bullock, S.L., Wilson, V.A., Price, D.J., Mason,
J.O., 2003. Speciﬁc modiﬁcation of heparan sulphate is required for normal cerebral
cortical development. Mech. Dev. 120, 1481–1488.
Meyers, E.N., Lewandoski, M., Martin, G.R., 1998. An Fgf8 mutant allelic series generated
by Cre- and Flp-mediated recombination. Nat. Genet. 18, 136–141.
Miller, D.L., Ortega, S., Bashayan, O., Basch, R., Basilico, C., 2000. Compensation by
ﬁbroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects
observed in FGF2 null mice. Mol. Cell. Biol. 20, 2260–2268.
Moon, A.M., Capecchi, M.R., 2000. Fgf8 is required for outgrowth and patterning of the
limbs. Nat. Genet. 26, 455–459.
Moon, A.M., Guris, D.L., Seo, J.H., Li, L., Hammond, J., Talbot, A., Imamoto, A., 2006. Crkl
deﬁciency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.
Dev. Cell 10, 71–80.
Ng, A., Wong, M., Viviano, B., Erlich, J.M., Alba, G., Pﬂederer, C., Jay, P.Y., Saunders, S., 2009.
Loss of glypican-3 function causes growth factor-dependent defects in cardiac and
coronary vascular development. Dev. Biol. 335, 208–215.
Ostrovsky, O., Berman, B., Gallagher, J., Mulloy, B., Fernig, D.G., Delehedde, M., Ron,
D., 2002. Differential effects of heparin saccharides on the formation of speciﬁc
ﬁbroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem. 277,
2444–2453.
Pallerla, S.R., Pan, Y., Zhang, X., Esko, J.D., Grobe, K., 2007. Heparan sulfate Ndst1 gene
function variably regulates multiple signaling pathways during mouse development.
Dev. Dyn. 236, 556–563.
Pan, Y., Woodbury, A., Esko, J.D., Grobe, K., Zhang, X., 2006. Heparan sulfate biosynthetic
gene Ndst1 is required for FGF signaling in early lens development. Development
133, 4933–4944.
Pan, Y., Carbe, C., Powers, A., Zhang, E.E., Esko, J.D., Grobe, K., Feng, G.S., Zhang, X., 2008.
Bud speciﬁc N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling
during lacrimal gland induction. Development 135, 301–310.
Park, E.J., Ogden, L.A., Talbot, A., Evans, S., Cai, C.L., Black, B.L., Frank, D.U., Moon, A.M.,
2006. Required, tissue-speciﬁc roles for Fgf8 in outﬂow tract formation and remodel-
ing. Development 133, 2419–2433.
Park, E.J., Watanabe, Y., Smyth, G., Miyagawa-Tomita, S., Meyers, E., Klingensmith, J.,
Camenisch, T., Buckingham, M., Moon, A.M., 2008. An FGF autocrine loop initiated
in second heart ﬁeld mesoderm regulates morphogenesis at the arterial pole of the
heart. Development 135, 3599–3610.
Pennisi, D.J., Ballard, V.L., Mikawa, T., 2003. Epicardium is required for the full rate of
myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2
and its receptor, FGFR-1, but not for transmural myocardial patterning in the embry-
onic chick heart. Dev. Dyn. 228, 161–172.
Porras, D., Brown, C.B., 2008. Temporal–spatial ablation of neural crest in the mouse
results in cardiovascular defects. Dev. Dyn. 237, 153–162.
Qu, X., Hertzler, K., Pan, Y., Grobe, K., Robinson, M.L., Zhang, X., 2011. Genetic epistasis
between heparan sulfate and FGF-Ras signaling controls lens development. Dev.
Biol. 355, 12–20.
Qu, X., Pan, Y., Carbe, C., Powers, A., Grobe, K., Zhang, X., 2012. Glycosaminoglycan-
dependent restriction of FGF diffusion is necessary for lacrimal gland development.
Development 139, 2730–2739.
Rapraeger, A.C., Krufka, A., Olwin, B.B., 1991. Requirement of heparan sulfate for
bFGF-mediated ﬁbroblast growth and myoblast differentiation. Science 252,
1705–1708.
Ringvall, M., Ledin, J., Holmborn, K., Van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson,
A.M., Kjellén, L., Forsberg, E., 2000. Defective heparan sulfate biosynthesis and
neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J. Biol.
Chem. 275, 25926–25930.
Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Friedman, R., Boivin, G.P.,
Cardell, E.L., Doetschman, T., 1997. TGFbeta2 knockout mice have multiple develop-
mental defects that are non-overlapping with other TGFbeta knockout phenotypes.
Development 124, 2659–2670.
Schneider, R.A., Hu, D., Rubenstein, J.L., Maden, M., Helms, J.A., 2001. Local retinoid signal-
ing coordinates forebrain and facial morphogenesis by maintaining FGF8 and SHH.
Development 128, 2755–2767.
Schultz, J.E., Witt, S.A., Nieman, M.L., Reiser, P.J., Engle, S.J., Zhou, M., Pawlowski, S.A.,
Lorenz, J.N., Kimball, T.R., Doetschman, T., 1999. Fibroblast growth factor-2 mediates
pressure-induced hypertrophic response. J. Clin. Invest. 104, 709–719.
Song, L., Li, Y., Wang, K., Zhou, C.J., 2010. Cardiac neural crest and outﬂow tract defects in
Lrp6 mutant mice. Dev. Dyn. 239, 200–210.
Sun, X., Meyers, E.N., Lewandoski, M., Martin, G.R., 1999. Targeted disruption of Fgf8 causes
failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13, 1834–1846.
van den Born, J., Salmivirta, K., Henttinen, T., Ostman, N., Ishimaru, T., Miyaura, S., Yoshida,
K., Salmivirta, M., 2005. Novel heparan sulfate structures revealed by monoclonal an-
tibodies. J. Biol. Chem. 280, 20516–20523.
Washington Smoak, I., Byrd, N.A., Abu-Issa, R., Goddeeris, M.M., Anderson, R., Morris, J.,
Yamamura, K., Klingensmith, J., Meyers, E.N., 2005. Sonic hedgehog is required for
cardiac outﬂow tract and neural crest cell development. Dev. Biol. 283, 357–372.
Watanabe, Y., Miyagawa-Tomita, S., Vincent, S.D., Kelly, R.G., Moon, A.M.,
Buckingham, M.E., 2010. Role of mesodermal FGF8 and FGF10 overlaps in the
265Y. Pan et al. / Matrix Biology 35 (2014) 253–265development of the arterial pole of the heart and pharyngeal arch arteries. Circ.
Res. 106, 495–503.
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., Ornitz, D.M., 1991. Cell surface, heparin-like
molecules are required for binding of basic ﬁbroblast growth factor to its high afﬁnity
receptor. Cell 64, 841–848.
Zhang, X., Ibrahimi, O.A., Olsen, S.K., Umemori, H., Mohammadi, M., Ornitz, D.M., 2006.
Receptor speciﬁcity of the ﬁbroblast growth factor family the complete mammalian
FGF family. J. Biol. Chem. 281, 15694–15700.Zhang, J., Lin, Y., Zhang, Y., Lan, Y., Lin, C., Moon, A.M., Schwartz, R.J., Martin, J.F.,
Wang, F., 2008. Frs2alpha-deﬁciency in cardiac progenitors disrupts a subset
of FGF signals required for outﬂow tract morphogenesis. Development 135,
3611–3622.
Zhou, M., Sutliff, R.L., Paul, R.J., Lorenz, J.N., Hoying, J.B., Haudenschild, C.C., Yin, M., Cofﬁn,
J.D., Kong, L., Kranias, E.G., Luo, W., Boivin, G.P., Duffy, J.J., Pawlowski, S.A.,
Doetschman, T., 1998. Fibroblast growth factor 2 control of vascular tone. Nat. Med.
4, 201–207.
